Healthcare Exclusives Pressreleases
Medneo acquires Ramsay Health Care UK mobile imaging assets and enters long-term national diagnostics partnership
Wednesday, July 01, 2026The multimillionpound agreement includes the acquisition of Ramsay Diagnostics UK Ltds RDUK mobile MRI and CT fleet and a sixyear exclusive contract to provide mobile imaging services across Ramsays
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
Monday, April 13, 2026Roche announced today that its Elecsys Neurofilament Light Chain NfL test has received CE mark approval for the detection of neuroinflammation in patients diagnosed with relapsing remitting multiple sclerosis RRMS
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Tuesday, March 10, 2026Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular a company with critical innovative technology across the neurovascular portfolio
Immunovia receives state regulatory approval for PancreaSure in California and initiates commercial rollout
Monday, January 19, 2026Immunovia AB a pancreatic cancer diagnostics company today announced that it has received regulatory approval for its PancreaSure test in California US enabling commercial sales in the state
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI
Monday, December 15, 2025Royal Philips NYSE PHG AEX PHIA a global leader in health technology today announced it has entered into an agreement to acquire SpectraWAVE Inc an innovator
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
Wednesday, October 29, 2025Medtronic plc a global leader in healthcare technology today announced that the Centers for Medicare Medicaid Services CMS has released the final National Coverage Determination NCD on renal denervation
PancreaSure clinical validation data to be presented at the American Gastroenterology Annual Scientific Meeting
Monday, October 27, 2025Immunovia the pancreatic cancer diagnostics company today announced that its abstract on the CLARITI and VERIFI validation studies for the PancreaSure test has been accepted for an oral plenary presentation at the prestigious
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
Wednesday, October 08, 2025Medtronic plc today announced the start of the Embrace Gynecology investigational device exemption IDE US clinical study to evaluate the safety and effectiveness of its Hugo roboticassisted surgery RAS system in roboticassisted gynecological procedur...
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
Friday, September 19, 2025Medtronic plc a global leader in healthcare technology announced today that it has received US Food and Drug Administration FDA approval for the Altaviva device The minimally invasive implantable tibial neuromodulation
Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
Thursday, September 11, 2025Royal Philipsa global leader in health technology and Masimo NASDAQ MASI today announced that the two companies have renewed their multiyear strategic collaboration marking a fresh chapter in their longstanding partnership
